Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position

April 30, 2024

https://www.globenewswire.com/news-release/2024/04/30/2872110/0/en/Invivyd-Announces-20-Million-to-25-Million-Improvement-in-Projected-2024-Year-End-Cash-Position.html

WALTHAM, Mass., April 30, 2024 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq:IVVD), a biopharmaceutical company devoted to protection from serious viral infectious diseases, today announced that following a comprehensive strategic review, the company is improving its projected 2024 year-end cash position by approximately $20 million to $25 million. Invivyd now expects to end 2024 with at least $75 million in cash and cash equivalents.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.